Immuron achieves record half yearly Travelan® sales

January 19, 2024

https://www.globenewswire.com/news-release/2024/01/16/2809637/37134/en/Immuron-achieves-record-half-yearly-Travelan-sales.html

Highlights:

MELBOURNE, Australia, Jan. 16, 2024 (GLOBE NEWSWIRE) — Immuron Limited (ASX:IMC; NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce record half yearly sales (unaudited net sales) of its over-the-counter gastrointestinal and digestive health immune supplement Travelan®.

Read more at globenewswire.com

Related news for (IMRN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.